Platinum‐containing regimens for triple‐negative metastatic breast cancer

Review (10 studies, n=1,349) reports that for women with metastatic triple‐negative breast cancer, there was moderate‐quality evidence of a small survival benefit from platinum‐based regimens compared to non‐platinum regimens.

Source:

Cochrane Database of Systematic Reviews